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Introduction 
Anticoagulant rodenticides (AVK) are known to accumulate substantially in the liver of exposed 
animals. Their half-lives are very long; up to 350 days for brodifacoum in rats (Erickson and Urban, 
2002). As a consequence, secondary poisoning occurs in predators and scavengers feeding regularly on 
poisoned animals (Berny et al., 1997, Shore et al., 1999). This has been observed in many species, 
including endangered species such as the red kite (Milvus milvus) (Berny and Gaillet, 2008). In Europe, 
rodenticide resistance appears to be widely distributed. There is strong evidence supporting the role of 
the Vkorc1 gene in the resistance of the Norway rat (Rattus norvegicus) (Rost et al., 2004) and several 
SNPs’ associated with resistance have been identified (Pelz et al., 2005). The objective of this work is to 
analyze the potential for bioaccumulation of given anticoagulant compounds in resistant rats from 
various European strains. The hypothesis tested was that resistant strains should accumulate 
anticoagulants to a larger extent than susceptible rats. 
Materials and methods 
Resistant rats were obtained from Germany (Dr. Jens Jacob), United Kingdom (Dr. Alan McNicoll) and 
France, carrying respectively the Y139C, L120Q (Berkshire strain) and Y139F resistance mutations. 
Susceptible rats were obtained from our own breeding colony. The genetic status of each strain was 
verified with DNA sequencing (homozygous resistant animals). The resistance status of each strain has 
already been published (Pelz et al., 2005). Rats were fed ad libitum on a wheat-bait containing 
chlorophacinone (50 mg/kg). This anticoagulant was chosen because it is one of the most commonly 
used in France and also because all strains are known to be resistant to a significant extent to this AVK. 
Four animals of each strain (2 males, 2 females) were euthanized after 1, 4, 9 or 14 days of continuous 
exposure. A second series of exposure was conducted on rats exposed 3 days on day 3, 8 and 13 and 
euthanized at days 4, 9 and 14. PT time was determined on the day of euthanasia for each rat. 
Chlorophacinone and its major hydroxyl metabolites were analyzed by HPLC with UV detection in 
plasma and liver samples for all animals. 
Results 
The resistance status of the strain had a definite effect on the survival rate at day 14 and on the time-to 
death. Resistance was L120Q > Y139C=Y139F, as confirmed by mean time to death and elevation of 
PT. Daily consumption of chlorophacinone was fairly consistent for all strains and during the entire 
study period with a mean of 3.0 mg/kg/day (LD50: 2.1 mg/kg). Accumulation of chlorophacinone was 
clearly dose-dependent for the first week (i.e. day 4), at least for the parent compound (Figure 1). 
Accumulation seemed to stop during the second week in all strains except L120Q. No significant 
differences could be detected between strains after 4 days. At Day 9 or 14, differences were noted, 
especially related to the time of death, which was clearly strain dependent. Overall, L120Q rats 
accumulated higher concentrations of chlorophacinone in the liver than other resistant strains and 
susceptible rats (incomplete data at the time of abstract submission). Metabolites accumulated somewhat 
in the liver but with no apparent dose-dependent relationship. Among the four different durations of 
exposure (days 1, 4, 9 and 14) accumulation occurred to a less significant extent. (Plasma and some liver 
samples are still being analyzed at the time of submission of this abstract). 
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Fig. 1 Liver accumulation of chlorophacinone (Chloro) after 1 week in resistant rats (data combined for all 
strains). 
Discussion 
Published work regarding AVK accumulation in resistant rats is very limited so far. Atterby et al. (2005) 
compared whole-body residues of the L120Q strains (both Hampshire and Berkshire, the latter being 
resistant to difenacoum) and found no significant difference between susceptible and resistant strains. In 
their study, the authors showed that whole body concentrations peaked after 3 days and remained 
constant over 20 days of feeding. These results are quite different from ours, but the study design was 
also very different: we chose chlorophacinone, because all the strains were known to be strongly resistant 
and we analyzed only the liver, known to be the cumulative site of contamination of many mammalian 
species, rather than whole bodies. Since the liver is also rapidly consumed by predators, this choice 
appeared more appropriate to investigate potential ecotoxicological impacts of the anticoagulant. Our 
results clearly show that resistant rats may carry more AVK in their body than susceptible rodents, 
therefore they represent a greater risk to predators and scavengers feeding on them.  
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